Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Salesforce Files S-8 to Register $400M Deferred Comp Plan

Salesforce, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 2, 2026, to register $400,000,000 in deferred compensation obligations under the newly established Salesforce, Inc. Executive Deferred Compensation Plan.

Aakashdeep | 02 November 2026

Eastern International Ltd. Seeks $4.5M in 12.5M Share Offering

Eastern International Ltd. filed a Form F-1 registration statement with the U.S. Securities and Exchange Commission on November 2, 2026, seeking to raise up to $4,500,000 through a best-efforts offering of 12,500,000 ordinary shares at an assumed price of $0.36 per share.

Manish Choudhary | 02 November 2026

Intelligent Bio Solutions Files 10-K for Fiscal Year Ended June 30, 2026

Intelligent Bio Solutions Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission covering the fiscal year ended June 30, 2026, disclosing company financials, risk factors, and governance information as a smaller reporting company listed on NASDAQ:INBS.

Aditi Sarkar | 02 November 2026

Equitable Holdings Reports Q3 2026 Financial Results

Equitable Holdings, Inc. filed a Form 8-K with the SEC on November 2, 2026, announcing its financial results for the quarter ended September 30, 2026, along with a Financial Supplement and an investor presentation tied to its earnings call.

Aditi Sarkar | 02 November 2026

Colony Bankcorp Registers 30,576 Shares for First Reliance RSUs

Colony Bankcorp, Inc. filed a Form S-8 registration statement with the Securities and Exchange Commission on November 2, 2026, to register 30,576 shares of common stock issuable upon the vesting and settlement of restricted stock unit awards assumed in connection with its merger with …

Manish Choudhary | 02 November 2026

Grindr Closes PurposeMed Acquisition for Up to $320M

Grindr Inc. filed a Form 8-K with the SEC on November 2, 2026, disclosing the completion of its acquisition of PurposeMed Inc. for an upfront purchase price of approximately $250.0 million, with potential additional earnout consideration of up to $70.0 million.

Vinay Lochav | 02 November 2026

Lindsay Corp Names Michael Koch CFO, Effective Nov. 9

Lindsay Corporation filed a Form 8-K on November 2, 2026, disclosing the appointment of Michael Koch as Senior Vice President and Chief Financial Officer, effective November 9, 2026.

Shwetambri Chauhan | 02 November 2026

John Moorhead Joins Femasys Board as Class II Director

Femasys Inc. filed a Form 8-K on November 2, 2026, reporting the resignation of director Kenneth D. Eichenbaum, M.D., M.S.E. and the appointment of John Moorhead as a Class II director of the company, both effective October 30, 2026.

Shwetambri Chauhan | 02 November 2026

Arrive AI Redomesticates from Delaware to Nevada Oct. 27

Arrive AI Inc. filed a Form 8-K on November 2, 2026, disclosing that the company completed its redomestication from a Delaware corporation to a Nevada corporation, effective October 27, 2026.

Anjali Anand | 02 November 2026

GoodRx Flags Pharma Direct Revenue Understatement in Q1 and Q2 2026

GoodRx Holdings, Inc. filed a Form 8-K on November 2, 2026, disclosing that its Audit and Risk Committee concluded on October 27, 2026, that previously issued financial statements for the fiscal quarters ended March 31, 2026 and June 30, 2026 should no longer be …

Aakashdeep | 02 November 2026
Support

Hi! How can we help you today?

Loading…